The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
Yi C, Mu L, de la Longrais IA, Sochirca O, Arisio R, Yu H, Hoffman AE, Zhu Y, Katsaro D.
Yi C, et al. Among authors: hoffman ae.
Breast Cancer Res Treat. 2010 Apr;120(3):663-9. doi: 10.1007/s10549-009-0484-0. Epub 2009 Aug 1.
Breast Cancer Res Treat. 2010.
PMID: 19649706
Free PMC article.